Searched for
SANOFIAVENTIS
Glenmark gets tentative FDA nod for Sanofi's generic MultaqHowever, the company cannot sell the product in the US as it is involved in a patent litigation with Sanofi in the district court of Delawa...- Sanofi-Aventis in advanced talks to buy majority stake in Universal Medicare to scale up OTC biz in IndiaAccording to a person close to the deal, Sanofi-Aventis may buy a majority stake or key brands valuing the Indian company at around Rs 450 ...
- Dr Reddy's launches Fexofenadine HCl in USDr Reddy's Laboratories today announced the launch of generic version of Allegra -- Fexofenadine HCl -- tablets in the US market.
- Sanofi extends $18.5 bn bid for Genzyme againIn a statement Sanofi-aventis said its offer of $69 per Genzyme share was extended till February 15 midnight.
- Sanofi extends $18.5bn offer for Genzyme till Jan 21Sanofi-aventis has a significant presence in India. Last year, Sanofi-aventis had sought to acquire an 80pc stake in ShanthaBiotechnics for...
- Sanofi extends bid for GenzymeFrench pharmaceutical giant Sanofi-Aventis said Monday it had extended its bid for US biotechnology group Genzyme without improving the off...
- Sanofi-Aventis likely to buy Genzyme for USD 19 bn: ReportFrench drug maker Sanofi-Aventis is likely to make an formal offer to acquire US-based biotech company Genzyme for USD 19 billion, says a m...
- Sanofi plans mega US deal to counter sales dipSanofi-Aventis, France’s biggest drugmaker, is preparing a major acquisition in the US, according to five people with knowledge of the situ...
- Glenmark surges 12% on BSE on Sanofi-Aventis licensing pactShares of pharma firm Glenmark Pharmaceuticals today vaulted by 12 per cent on the Bombay Stock Exchange to touch a year-high of Rs 303.80 ...
- Sun's EPS may take a knock if it stops cancer drug saleThe stock of Sun Pharma fell for a fourth day in a row, as investors are worried about the company's legal tussle with Sanofi-Aventis over ...
- Sanofi-Aventis to buy Chattem for $1.9 bnFrench drug maker Sanofi-Aventis SA to buy US health care company Chattem Inc for about $1.9 billion in cash.
- Piramal Health up 13% on Sanofi stake buyThe news of French drug major Sanofi-Aventis picking up stake in Piramal Healthcare at a premium has resulted in its stock price trading at...
- Sanofi seen ahead in Piramal raceSanofi-Aventis has completed due diligence and the deal could be closed soon, one of the two persons told ET on condition of anonymity.
- Zentiva recommends shareholders reject Sanofi Aventis' bidThe board of Czech generic drugs maker Zentiva N.V. said it has recommended that its shareholders reject a takeover offer from French pharm...
- Sanofi to eclipse Sun’s Eloxatin planFrance’s largest pharma company, Sanofi-Aventis, is suing India’s Sun Pharmaceuticals and Hospira’s Mayne Pharma to prevent the latter from...
- Sanofi-Aventis files patent case against Dabur Pharma in USFrench pharma major, Sanofi-Aventis, has filed a lawsuit in the US District Court of New Jersey challenging Dabur Pharma Limited’s Para-1V ...
- US firm files suit against Dabur PharmaUS-based Sanofi-Aventis LLC has filed a lawsuit against Dabur Pharma and its UK arm - Dabur Oncology Pte, over a USFDA filing seeking appro...
- Plavix copies hit Sanofi-Aventis, net drops 12%Sanofi-aventis reported a 12% drop in third-quarter profit on Tuesday, citing the loss of top-selling blood thinner Plavix to generic compe...
- Lupin loses patent suit in AmericaPharmaceutical company Lupin on Thursday said a district court in the US has ruled against the company in a patent infringement suit.
- Sanofi-Aventis revises open offer for Aventis PharmaThe schedule of Sanofi-Aventis' open offer for shareholders of Aventis Pharma Ltd has been revised by DSP Merrill Lynch, manager of the off...
Load More- Sanofi extends $18.5 bn bid for Genzyme again
